Network meta-analysis of Chinese patent medicines combined with clomiphene for ovulatory infertility
Citation
Network meta-analysis of Chinese patent medicines combined with clomiphene for ovulatory infertility. https://hnyy.cbpt.cnki.net/portal/journal/portal/client/paper/3c75482309f96d762506bc4d37ead497
| Publication Year | 2024 |
|---|---|
| DOI | 10.13210/j.cnki.jhmu.20230615.001 |
Study Details
| Study Design | Meta-analysis |
|---|---|
| Evidence Level | Limited human evidence |
| Population | Women with ovulatory infertility across trials of 12 Chinese patent medicines |
| Sample Size | 2647 |
| Intervention | Tiaojingcuyun Pills plus clomiphene within a network of combination regimens |
| Comparator | Clomiphene and other Chinese patent medicine plus clomiphene regimens |
Outcomes
Tiaojingcuyun Pills plus clomiphene ranked highest for pregnancy rate among the regimens compared. Limited trial quality and indirect comparisons make that ranking uncertain.
Results
Tiaojingcuyun Pills plus clomiphene ranked highest for pregnancy rate among the regimens compared. Limited trial quality and indirect comparisons make that ranking uncertain.
Limitations
Abstract-level appraisal; indirect comparisons and limited trial quality. Target-specific effect estimate and sample size unavailable. Trial overlap with other reviews must not be counted as independent participants.
Related Product
- Tiaojing Cuyun Wan